Ticker Details
Zevra Therapeutics, Inc.
IPO Date:	April 13, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$495.42M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 2.48%
Avg Daily Range (30 D):	$0.16 | 1.87%
Avg Daily Range (90 D):	$0.20 | 2.16%

Institutional Daily Volume
Avg Daily Volume:	.57M
Avg Daily Volume (30 D):	.73M
Avg Daily Volume (90 D):	.99M

Trade Size
Avg Trade Size (Sh.):	91
Avg Trade Size (Sh.) (30 D):	78
Avg Trade Size (Sh.) (90 D):	82

Institutional Trades
Total Institutional Trades:	278
Avg Institutional Trade:	$1.25M
Avg Institutional Trade (30 D):	$1.55M
Avg Institutional Trade (90 D):	$1.17M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.28M
Avg Closing Trade (30 D):	$.84M
Avg Closing Trade (90 D):	$.92M
Avg Closing Volume:	150.36K

News

Oct 6, 2025 @ 9:51 PM Zevra Therapeutics Announces Inducement Grants und... Source: Nichol Ochsner

Feb 27, 2025 @ 12:30 PM Zevra Therapeutics Enters Agreement to Sell its Ra... Source: Globe Newswire

Dec 6, 2024 @ 10:00 PM Zevra Therapeutics Announces Organizational Change... Source: N/A

Nov 21, 2024 @ 9:51 PM Zevra Therapeutics Announces U.S. Commercial Avail... Source: N/A

Nov 11, 2024 @ 9:36 PM Zevra Therapeutics to Present Data Demonstrating R... Source: Zevra Therapeutics, Inc.

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.01	$1.24	$-.06
Diluted EPS	$-.01	$1.21	$-.04
Revenue	$26.06M	$25.88M	$20.4M
Gross Profit
Net Income / Loss	$-.54M	$74.71M	$-3.1M
Operating Income / Loss	$4.14M	$-71.04M	$-5.36M
Cost of Revenue
Net Cash Flow	$6.66M	$9.71M	$3.93M
PE Ratio

Splits
Dec 28, 2020	1:16